With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm
Top Story
Archived
•
November 3, 2025
•
The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.
Source: https://rss.nytimes.com/services/xml/rss/nyt/HomePage.xml - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



